Lænkholm AV - Search Results

1

PAM50 Risk of Recurrence Score Predicts 10-Year Distant Recurrence in a Comprehensive Danish Cohort of Postmenopausal Women Allocated to 5 Years of Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer.

Lænkholm AV, Jensen MB, Eriksen JO, Rasmussen BB, Knoop AS, Buckingham W, Ferree S, Schaper C, Nielsen TO, Haffner T, Kibøl T, Møller Talman ML, Bak Jylling AM, Tabor TP, Ejlertsen B. Lænkholm AV, et al. J Clin Oncol. 2018 Mar 10;36(8):735-740. doi: 10.1200/JCO.2017.74.6586. Epub 2018 Jan 25. J Clin Oncol. 2018. PMID: 29369732

2

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.

Knoop A, Andreasen PA, Andersen JA, Hansen S, Laenkholm AV, Simonsen AC, Andersen J, Overgaard J, Rose C. Knoop A, et al. Among authors: laenkholm av. Br J Cancer. 1998 Mar;77(6):932-40. doi: 10.1038/bjc.1998.154. Br J Cancer. 1998. PMID: 9528837 Free PMC article.

3

Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array.

Lyng MB, Laenkholm AV, Pallisgaard N, Vach W, Knoop A, Bak M, Ditzel HJ. Lyng MB, et al. Among authors: laenkholm av. Cell Oncol. 2007;29(5):361-72. doi: 10.1155/2007/860194. Cell Oncol. 2007. PMID: 17726259 Free PMC article.

4

Breast cancer in situ. From pre-malignant lesion of uncertain significance to well-defined non-invasive malignant lesion. The Danish Breast Cancer Cooperative Group Register 1977-2007 revisited.

Laenkholm AV, Jensen MB, Kroman N, Rank F. Laenkholm AV, et al. Acta Oncol. 2008;47(4):765-71. doi: 10.1080/02841860802043931. Acta Oncol. 2008. PMID: 18465346

5

Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer.

Nielsen KV, Ejlertsen B, Müller S, Møller S, Rasmussen BB, Balslev E, Lænkholm AV, Christiansen P, Mouridsen HT. Nielsen KV, et al. Among authors: laenkholm av. Breast Cancer Res Treat. 2011 Jun;127(2):345-55. doi: 10.1007/s10549-010-0984-y. Epub 2010 Jun 17. Breast Cancer Res Treat. 2011. PMID: 20556506

6

PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer.

Dupont Jensen J, Laenkholm AV, Knoop A, Ewertz M, Bandaru R, Liu W, Hackl W, Barrett JC, Gardner H. Dupont Jensen J, et al. Among authors: laenkholm av. Clin Cancer Res. 2011 Feb 15;17(4):667-77. doi: 10.1158/1078-0432.CCR-10-1133. Epub 2010 Oct 12. Clin Cancer Res. 2011. PMID: 20940279 Free article.

7

ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.

Jensen JD, Knoop A, Ewertz M, Laenkholm AV. Jensen JD, et al. Among authors: laenkholm av. Breast Cancer Res Treat. 2012 Apr;132(2):511-21. doi: 10.1007/s10549-011-1610-3. Epub 2011 Jun 11. Breast Cancer Res Treat. 2012. PMID: 21667123

8

Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.

Christiansen P, Bjerre K, Ejlertsen B, Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen B, Toftdahl DB, Møller S, Mouridsen HT; Danish Breast Cancer Cooperative Group. Christiansen P, et al. Among authors: laenkholm av. J Natl Cancer Inst. 2011 Sep 21;103(18):1363-72. doi: 10.1093/jnci/djr299. Epub 2011 Aug 31. J Natl Cancer Inst. 2011. PMID: 21881042

9

PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab.

Jensen JD, Knoop A, Laenkholm AV, Grauslund M, Jensen MB, Santoni-Rugiu E, Andersson M, Ewertz M. Jensen JD, et al. Among authors: laenkholm av. Ann Oncol. 2012 Aug;23(8):2034-2042. doi: 10.1093/annonc/mdr546. Epub 2011 Dec 15. Ann Oncol. 2012. PMID: 22172323 Free article.

10

Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy.

Larsen MS, Bjerre K, Giobbie-Hurder A, Lænkholm AV, Henriksen KL, Ejlertsen B, Lykkesfeldt AE, Rasmussen BB. Larsen MS, et al. Among authors: laenkholm av. Acta Oncol. 2012 Jul;51(6):781-9. doi: 10.3109/0284186X.2011.653009. Epub 2012 Mar 30. Acta Oncol. 2012. PMID: 22462654 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page